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Abstract
Requirements about the quality of clinical guidelines can be represented by schemata
borrowed from the theory of abductive diagnosis, using temporal logic to model the time-
oriented aspects expressed in a guideline. Previously, we have shown that these require-
ments can be verified using interactive theorem proving techniques. In this paper, we
investigate how this approach can be mapped to the facilities of a resolution-based the-
orem prover, otter, and a complementary program that searches for finite models of
first-order statements, mace-2. It is shown that the reasoning required for checking the
quality of a guideline can be mapped to such fully automated theorem-proving facilities.
The medical quality of an actual guideline concerning diabetes mellitus 2 is investigated
in this way.
KEYWORDS: automated reasoning, clinical guideline, temporal logic, abduction
1 Introduction
Health-care is becoming more and more complicated at an astonishing rate. On the
one hand, the number of different patient management options has risen consider-
ably during the last couple of decades, whereas, on the other hand, medical doctors
are expected to take decisions balancing benefits for the patient against financial
costs. There is a growing trend within the medical profession to believe that clinical
decision-making should be based as much as possible on sound scientific evidence;
this has become known as evidence-based medicine (Woolf 2000). Evidence-based
medicine has given a major impetus to the development of clinical guidelines, doc-
uments offering a description of steps that must be taken and considerations that
must be taken into account by health-care professionals in managing a disease in a
patient, to avoid substandard practices or outcomes. Their general aim is to pro-
mote standards of medical care. Clinical protocols have a similar aim as clinical
guidelines, except that they offer more detail, and are often local, more detailed
version of a related clinical guideline.
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Researchers in artificial intelligence (AI) have picked up on these developments by
designing guideline modelling languages, for instance PROforma (Fox and Das 2000)
and GLIF3 (Peleg et al. 2000) that may be useful in developing computer-based
representations of guidelines. Some of them, for example in the Asgaard project
(Shahar et al. 1998), in the CREDO project (Fox et al. 2006) and the GLARE
project (Terenziani et al. 2001; Terenziani et al. 2003), are also involved in the de-
sign of tools that support the deployment of clinical guidelines. These languages and
tools have been evolving since the 1990s, a process that is gaining momentum due
to the increased interest in guidelines within the medical community. AI researchers
see guidelines as good real-world examples of highly structured, systematic docu-
ments that are amenable to formalisation.
Compared to the amount of work that has been put into the formalisation of
clinical guidelines, verification of guidelines has received relatively little attention.
In (Shiffman and Greenes 1994), logic was used to check whether a set of rec-
ommendations is complete, to find out whether or not the recommendations are
logically consistent, and to recognise ambiguous rules if they are present. Check-
ing the consistency of temporal scheduling constraints has also been investigated
(Duftschmid et al. 2002). Most of the work done in the area of formal verification
of clinical guidelines, i.e., proving correctness properties using formal methods, is
of more recent years, e.g., as done in the Protocure project1 with the use of inter-
active theorem proving (Hommersom et al. 2007; Ten Teije et al. 2006) and model
checking (Ba¨umler et al. 2006; Groot et al. 2007).
This paper explores the use of automated deduction for the verification of clinical
guidelines. For the rapid development of good quality guidelines it is required that
guidelines can be at least partially verified automatically; unfortunately, as of yet,
there are no verification methods that can be readily used by guideline developers.
Previously, it was shown that for reasoning about models of medical knowledge,
for example in the context of medical expert systems (Lucas 1993), classical auto-
mated reasoning techniques (e.g., (Robinson 1965; Wos et al. 1984)) are a practical
option. Important for the reasoning about knowledge in clinical guidelines is its
temporal nature; time plays a part in the physiological mechanisms as well as in
the exploration of treatment plans. As far as we know, the application of automated
reasoning techniques to guideline knowledge has as yet not been investigated. The
guideline we studied to this purpose has a structure similar to other guidelines and
the verification principles used have sufficient generality. Thus, the results of the
study go beyond the actual guideline studied.
There are two approaches to checking the quality of clinical guidelines using for-
mal methods: (1) the object-level approach amounts to translating a guideline to
a formal language, such as Asbru (Shahar et al. 1998), and subsequently apply-
ing program verification or logical methods to analyse the resulting representation
for establishing whether certain domain-specific properties hold; (2) the meta-level
approach, which consists of formalising general requirements to which a guideline
1 http://www.protocure.org [Accessed: 21 May 2008]
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should comply, and then investigating whether this is the case. Here we are con-
cerned with the meta-level approach to guideline-quality checking. For example, a
good-quality clinical guideline regarding treatment of a disorder should preclude
the prescription of redundant drugs, or advise against the prescription of treatment
that is less effective than some alternative. An additional goal of this paper is to
establish how feasible it is to implement such meta-reasoning techniques in exist-
ing tools for automated deduction for the purpose of quality checking of a clinical
guideline.
Previously, we have shown that the theory of abductive diagnosis can be taken
as a foundation for the formalisation of quality criteria of a clinical guideline
(Lucas 2003) and that these can be verified using (interactive) program verifica-
tion techniques (Hommersom et al. 2007). In this paper, we provide an alternative
to this approach by translating this formalism, a restricted part of temporal logic,
to standard first-order logic. Furthermore, the quality criteria are interpreted in
such a way that they can be stated in terms of a monotonic entailment relation. We
show that, because of the restricted language needed for the formalisation of the
guideline knowledge, the translation is a relatively simple fragment of first-order
logic which is amended to automated verification. Thus, we show that it is indeed
possible, while not easy, to cover the route from informal medical knowledge to a
logical formalisation and automated verification.
The meta-level approach that is used here is particularly important for the design
of clinical guidelines, because it corresponds to a type of reasoning that occurs dur-
ing the guideline development process. Clearly, quality checks are useful during this
process; however, the design of a guideline can be seen as a very complex process
where formulation of knowledge and construction of conclusions and corresponding
recommendations are intermingled. This makes it cumbersome to do interactive
verification of hypotheses concerning the optimal recommendation during the con-
struction of such a guideline, because guideline developers do not generally have
the necessary background in formal methods to construct such proofs interactively.
Automated theorem proving could therefore be potentially more beneficial for sup-
porting the guideline development process.
The paper is organised as follows. In the next section, we start by explaining
what clinical guidelines are, and a method for formalising guidelines by temporal
logic is briefly reviewed. In Section 3 the formalisation of guideline quality using a
meta-level scheme that comes from the theory of abductive diagnosis is described.
The guideline on the management of diabetes mellitus type 2 that has been used
in the case study is given attention in Section 4, and a formalisation of this is given
as well. An approach to checking the quality of this guideline using the reasoning
machinery offered by automated reasoning tools is presented in Section 5. Finally,
Section 6 discusses what has been achieved, and the advantages and limitations of
this approach are brought into perspective. In particular, we will discuss the role
of automated reasoning in quality checking guidelines in comparison to alternative
techniques such as model checking and interactive verification.
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• Step 1: diet
• Step 2: if Quetelet Index (QI) ≤ 27, prescribe a sulfonylurea drug; otherwise, pre-
scribe a biguanide drug
• Step 3: combine a sulfonylurea drug and biguanide (replace one of these by a α-
glucosidase inhibitor if side-effects occur)
• Step 4: one of the following:
— oral anti-diabetics and insulin
— only insulin
Fig. 1. Tiny fragment of a clinical guideline on the management of diabetes mellitus
type 2. If one of the steps s where s = 1, 2, 3 is ineffective, the management moves
to step s+ 1.
2 Framework
In this section, we review the basics about clinical guidelines and the temporal logic
used in the remainder of the paper.
2.1 Clinical Guidelines
A clinical guideline is a structured document, containing detailed advice on the
management of a particular disorder or group of disorders, aimed at health-care
professionals. As modern guidelines are based on scientific evidence, they contain
information about the quality of the evidence on which particular statements are
based; e.g., statements at the highest recommendation level are usually obtained
from randomised clinical trials (Woolf 2000).
The design of a clinical guideline is far from easy. Firstly, the gathering and clas-
sification of the scientific evidence underlying and justifying the recommendations
mentioned in a guideline are time consuming, and require considerable expertise
of the medical field concerned. Secondly, clinical guidelines are very detailed, and
making sure that all the information contained in the guideline is complete for the
guideline’s purpose, and based on sound medical principles is hard work.
An example of a part of a guideline is the following (translated) text:
1. refer to a dietist; check blood glucose after 3 months
2. in case (1) fails and Quetelet Index (QI) ≤ 27, then administer a sulfonylureum
derivate (e.g. tolbutamide, 500 mg 1 time per day, max. 1000 mg 2 per day) and in case of
Quetelet Index (QI) > 27 biguanide (500 mg 1 per day, max. 1000 mg 3 times per day);
start with lowest dosage, increase each 2-4 weeks if necessary
It is part of a real-world guideline for general practitioners about the treatment of
diabetes mellitus type 2. Part of this description includes details about dosage of
drugs at specific time periods. As we want to reason about the general structure of
the guideline, rather than about dosages or specific time periods, we have made an
abstraction as shown in Fig. 1. This guideline fragment is used in this paper as a
running example.
Guidelines can be as large as 100 pages; however, the number of recommenda-
tions they include are typically few. In complicated diseases, each type of disease
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is typically described in different sections of a guideline, which provides ways to
modularise the formalisation in a natural fashion. For example, in the Protocure
project, we have formalised an extensive guideline about breast cancer treatment,
which includes recommendations very similar in nature and structure to the ab-
straction shown in Fig. 1. In this sense, the fragment in Fig. 1 can be lookup upon
as one of the recommendations in any guideline whatever its size. Clinical protocols
are normally more detailed, and the abstraction used here will not be appropriate
if one wishes to consider such details in the verification process. For example, in
the Protocure project we also carried out work on the verification of a clinical pro-
tocol about the management of neonatal jaundice, where we focussed on the levels
of a substance in the blood (bilirubin) (Ten Teije et al. 2006). Clearly, in this case
abstracting away from substance levels would be inappropriate.
The conclusions that can be reached by the rest of the paper are relative to the
abstraction that was chosen. The logical methods that we employ are related to
this level of abstraction, even though other logical methods are available to deal
issues such as more detailed temporal reasoning (Moszkowski 1985) or probabil-
ities (Richardson and Domingos 2006; Kersting and De Raedt 2000), which might
be necessary for some guidelines or protocols. Nonetheless, where development of
an abstraction of a medical document will be necessary for any verification task,
the way it is done is dependent on what is being verified and the nature of the
document. The level of abstraction that we employ allow us to reason about the
structure and effects of treatments, which, in our view, is the most important aspect
of many guidelines.
One way to use formal methods in the context of guidelines is to automati-
cally verify whether or not a clinical guideline fulfils particular properties, such as
whether it complies with quality indicators as proposed by health-care profession-
als (Marcos et al. 2002). For example, using particular patient assumptions such as
that after treatment the levels of a substance are dangerously high or low, it is pos-
sible to check whether this situation does or does not violate the guideline. However,
verifying the effects of treatment as well as examining whether a developed clinical
guideline complies with global criteria, such as that it avoids the prescription of re-
dundant drugs, or the request of tests that are superfluous, is difficult to impossible
if only the guideline text is available. Thus, the capability to check whether a guide-
line fulfils particular medical objectives may require the availability of more medical
knowledge than is actually specified in a clinical guideline. How much additional
knowledge is required may vary from guideline to guideline. In the development of
the theory below it is assumed that at least some medical background knowledge is
required; the extent and the purpose of that background knowledge is subsequently
established using the diabetes mellitus type 2 guideline. The development, logical
implementation, and evaluation of a formal method that supports this process is
the topic of the remainder of the paper.
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Table 1. Used temporal operators; t stands for a time instance.
Notation Informal meaning Formal meaning
Hϕ ϕ has always been true in the past t  Hϕ iff ∀t′ < t : t′  ϕ
ϕUψ ϕ is true until ψ holds  ϕUψ iff ∃t′ ≥ t : t′  ψ
and ∀t′′ : t ≤ t′′ < t′ → t′′  ϕ
2.2 Using Temporal Logic in Clinical Guidelines
Many representation languages for formalising and reasoning about medical knowl-
edge have been proposed, e.g., predicate logic (Lucas 1993), (heuristic) rule-based
systems (Shortliffe 1974), and causal representations (Patil 1981). It is not uncom-
mon to abstract from time in these representations; however, as medical manage-
ment is very much a time-oriented process, guidelines should be looked upon in a
temporal setting. It has been shown previously that the step-wise, possibly iterative,
execution of a guideline, such as the example in Fig. 1, can be described precisely
by means of temporal logic (Ten Teije et al. 2006). In a more practical setting it
is useful to support the modelling process by means of tools. There is promising
research for maintaining a logical knowledge base in the context of the semantic
web (e.g., the Prote´ge´-OWL editor2), and the logical formalisation described in this
paper could profit from the availability of such tools.
The temporal logic that we use here is a modal logic, where relationships between
worlds in the usual possible-world semantics of modal logic is understood as time
order, i.e., formulae are interpreted in a temporal frame F = (T, <, I), where T is
the set of intervals or time points, < a time ordering, and I an interpretation of the
language elements with respect to T and <. The language of first-order logic, with
equality and unique names assumption, is augmented with the operators U, H, G, P,
and F, where the temporal semantics of the first two operators is defined in Table 1.
The last four operators are simply defined in terms of the first two operators:
 Pϕ↔ ¬H¬ϕ (somewhere in the past)
 Fϕ↔ ⊤Uϕ (now or somewhere in the future)
 Gϕ↔ ¬F¬ϕ (now and always in the future)
This logic offers the right abstraction level to cope with the nature of the temporal
knowledge in clinical guidelines required for our purposes.
Other modal operators added to the language of first-order logic include X, where
Xϕ has the operational meaning of an execution step, followed by execution of
program part ϕ. Even though this operator is not explicitly used in our formalisation
of medical knowledge, a principle similar to the semantics of this operator is used
in Section 5.5 for reasoning about the step-wise execution of the guideline.
In addition, axioms can be added that indicate that progression in time is linear
2 http://protege.stanford.edu/overview/protege-owl.html [Accessed: 21 May 2008]
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(there are other possible axiomatisations, such as branching time, see (Turner 1985)).
The most important of these are:
(1) Transitivity:  FFϕ→ Fϕ
(2) Backward linearity:  (Pϕ ∧ Pψ)→ (P(ϕ ∧ ψ) ∨ P(ϕ ∧ Pψ) ∨ P(Pϕ ∧ ψ))
(3) Forward linearity:  (Fϕ ∧ Fψ)→ (F(ϕ ∧ ψ) ∨ F(ϕ ∧ Fψ) ∨ F(Fϕ ∧ ψ))
Transitivity ensures that we can move along the time axis from the past into the
future; backward and forward linearity ensure that the time axis does not branch.
Consider, for example, axiom (3), which says that if there exists a time t when ϕ is
true, and a time t′ when ψ holds, then there are three possibilities: ϕ and ψ hold
at the same time, or at some time in the future ϕ and further away in the future ψ
hold; the meaning of the last disjunct is similar. Other useful axioms concern the
boundedness of time; assuming that time has no beginning and no end, gives rise
to the following axioms:  Hϕ→ Pϕ and  Gϕ→ Fϕ.
Alternative formal languages for modelling medical knowledge are possible. For
example, differential equations describing compartmental models that are used to
predict changes in physiological variables in individual patients have been shown
to be useful (e.g., (Magni et al. 2000; Lehmann 1998)). In the context of clinical
reasoning they are less useful, as they essentially concern levels of substances as a
function of time and, thus, do not offer the right level of abstraction that we are
after.
3 Application to Medical Knowledge
It is well-known that knowledge elicitation is difficult (see e.g., (Evans 1988)) and
due to complexity and uncertainty this is particularly true for medical knowledge
(see e.g., (van Bemmel and Musen 2002)). The effort to acquire this knowledge is
dependent on the availability of the knowledge in the guideline and the complexity
of the mechanisms that are involved in the development of the disease. For evidence-
based guidelines, a large part of the relevant knowledge required for checking the
quality of the recommendations is included in the guideline, which makes the prob-
lem more contained than the problem of arbitrary medical knowledge elicitation.
The purpose of a clinical guideline is to have a certain positive effect on the health
status of a patient to which the guideline applies. To establish that this is indeed the
case, knowledge concerning the normal physiology and abnormal, disease-related
pathophysiology of a patient is required. Some of this physiological knowledge may
be missing from the clinical guidelines; however, much of this knowledge can be
acquired from textbooks on medical physiology, which reduces the amount of effort
required to construct such knowledge models. The latter approach was taken in this
research.
It is assumed that two types of knowledge are involved in detecting the violation
of good medical practice:
• Knowledge concerning the (patho)physiological mechanisms underlying the
disease, and the way treatment influences these mechanisms. The knowledge
involved could be causal in nature, and is an example of object-knowledge.
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• Knowledge concerning good practice in treatment selection; this is meta-
knowledge.
Below we present some ideas on how such knowledge may be formalised using
temporal logic (cf. (Lucas 1995) for earlier work in the area of formal modelling of
medical knowledge).
We are interested in the prescription of drugs, taking into account their mode
of action. Abstracting from the dynamics of their pharmacokinetics, this can be
formalised in logic as follows:
(G d ∧ r)→ G(m1 ∧ · · · ∧mn) (1)
where d is the name of a drug, r is a (possibly negative or empty) requirement for the
drug to take effect, andmk is a mode of action, such as decrease of release of glucose
from the liver, which holds at all future times. Note that we assume that drugs are
applied for a long period of time, here formalised as ‘always’. This is reasonable if we
think of the models as finite structures that describe a somewhat longer period of
time, allowing the drugs to take effect. Synergistic effects and interactions amongst
drugs can also be formalised along those lines, as required by the guideline under
consideration. This can be done either by combining their joint mode of action, by
replacing d in the formula above by a conjunction of drugs, by defining harmful joint
effects of drugs in terms of inconsistency, or by reasoning about modes of actions. As
we do not require this feature for the clinical guideline considered in this paper, we
will not go into details. In addition, it is possible to reason about such effects using
special purpose temporal logics with abstraction and constraints, such as developed
by Allen (Allen 1983) and Terenziani (Terenziani 2000) without a connection to a
specific field, and by Shahar (Shahar 1997) for the field of medicine. Thus, temporal
logics are expressive enough to cope with extensions to the formalisation as used in
this paper.
The modes of actionmk can be combined, together with an intention n (achieving
normoglycaemia, i.e., normal blood glucose levels, for example), a particular patient
condition c, and requirements rj for the modes of action to be effective:
(Gmi1 ∧ · · · ∧ Gmim ∧ r1 ∧ · · · ∧ rp ∧ Hc)→ Gn (2)
For example, if the mode describes that there is a stimulus to secrete more insulin
and the requirement that sufficient capacity to provide this insulin is fulfilled, then
the amount of glucose in the blood will decrease.
Good practice medicine can then be formalised as follows. Let B be background
knowledge, T ⊆ {d1, . . . , dp} be a set of drugs, C a collection of patient conditions,
R a collection of requirements and N a collection of intentions which the physician
has to achieve. As an abbreviation, the union of C and R, i.e., the variables de-
scribing the patient, will be referred to as P , i.e., P = C∪R. Finding an acceptable
treatment given such knowledge amounts to finding an explanation, in terms of a
treatment, that the intention will be achieved. Finding the best possible explanation
given a number of findings is called abductive reasoning (Console and Torasso 1991;
Poole 1990). We say that a set of drugs T is a treatment according to the theory of
abductive reasoning if (Lucas 2003):
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(M1) B ∪ GT ∪ P 2 ⊥ (the drugs do not have contradictory effects), and
(M2) B ∪ GT ∪ P  N (the drugs handle all the patient problems intended to be
managed).
One could think of the formula B ∪ GT ∪ P as simulating a particular patient P
given a particular treatment T . For each relevant patient groups, these properties
can be investigated. If in addition to (M1) and (M2) condition
(M3) Oϕ(T ) holds, where Oϕ is a meta-predicate standing for an optimality cri-
terion or combination of optimality criteria ϕ, then the treatment is said to be
in accordance with good-practice medicine.
A typical example of this is subset minimality O⊂:
O⊂(T ) ≡ ∀T
′ ⊂ T : T ′ is not a treatment according to (M1) and (M2) (3)
i.e., the minimum number of effective drugs are being prescribed. For example, if
{d1, d2, d3} is a treatment that satisfies condition (M3) in addition to (M1) and
(M2), then the subsets {d1, d2}, {d2, d3}, {d1}, and so on, do not satisfy conditions
(M1) and (M2). In the context of abductive reasoning, subset minimality is often
used in order to distinguish between various solutions; it is also referred to in
literature as Occam’s razor. Another definition of the meta-predicate Oϕ is in terms
of minimal cost Oc:
Oc(T ) ≡ ∀T
′,with T ′ a treatment: c(T ′) ≥ c(T ) (4)
where c(T ) =
∑
d∈T cost(d); combining the two definitions also makes sense. For
example, one could come up with a definition of O⊂,c that among two subset-
minimal treatments selects the one that is the cheapest in financial or ethical sense.
The quality criteria that we have presented in this section could also be taken as
starting points for critiquing, i.e., criticising clinical actions performed and recorded
by a physician (cf. (Miller 1984) for an early critiquing system), especially if we
consider the formalisation of the background knowledge a model for simulating a
patient receiving a specific treatment. However, here we look for means to criticise
the recommendations given by the guidelines.
In order to verify the quality of guidelines, we do not make use of data from medi-
cal records. The use of such data is especially important if one wishes to empirically
evaluate the guideline. As data may be missing from the database—a very common
situation in clinical datasets—tests ordered for a patient and treatments given to
the patient may not be according to the guideline. Therefore, such datasets cannot
be used to identify problems with the clinical guideline. Results would tell as much
about the dataset as about the guidelines. Once the guideline has been shown to
be without flaws, it becomes interesting to carry out subsequent evaluation of the
guideline using patient data. These were the main reasons why we explored guide-
line quality by using well-understood and well-described data from hypothetical
patients; this simulates the way medical doctors would normally critically look at a
guideline. Notice the similarity with use-cases in software engineering. This method
is practical and possible, and could be used in the process of designing a guideline.
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4 Management of Diabetes Mellitus Type 2
To determine the global quality of the guideline, the background knowledge itself
was only formalised so far as required for investigating the usefulness of the theory
of quality checking introduced above. The knowledge that is presented here was
acquired with the help of a physician, though this knowledge can be found in many
standard textbooks on physiology (e.g., (Ganong 2005; Guyton and Hall 2000)).
4.1 Initial Analysis
It is well known that diabetes type 2 is a very complicated disease: various metabolic
control mechanisms are deranged and many different organ systems, such as the
cardiovascular and renal system, may be affected by the disorder. Here we focus
on the derangement of glucose metabolism in diabetic patients, and even that is
nontrivial. To support non-expert medical doctors in the management of this com-
plicated disease in patients, access to a guideline is really essential.
One would expect that as this disorder is so complicated, the diabetes mellitus
type 2 guideline is also complicated. This, however, is not the case, as may already
be apparent from the guideline fragment shown in Fig. 1. This indicates that much
of the knowledge concerning diabetes mellitus type 2 is missing from the guideline,
and that without this background knowledge it will be impossible to spot the sort
of flaws we are after. Hence, the conclusion is that a deeper analysis is required;
the results of such an analysis are discussed next.
4.2 Diabetes Type 2 Background Knowledge
Fig. 2 summarises the most important mechanisms and drugs involved in the control
of the blood level of glucose. The protein hormone insulin, which is produced by
the B cells in the Langerhans islets of the pancreas, has the following major effects:
• it increases the uptake of glucose by the liver, where it is stored as glycogen,
and inhibits the release of glucose from the liver;
• it increases the uptake of glucose by insulin-dependent tissues, such as muscle
and adipose tissue.
At some stage in the natural history of diabetes mellitus type 2, the level of glucose
in the blood is too high (hyperglycaemia) due to decreased production of insulin
by the B cells. A popular hypothesis explaining this phenomenon is that target
cells have become insulin resistant, which with a delay causes the production of
insulin by the B cells to raise. After some time, the B cells become exhausted, and
they are no longer capable of meeting the demands for insulin. As a consequence,
hyperglycaemia develops.
Treatment of diabetes type 2 consists of:
• Use of sulfonylurea (SU) drugs, such as tolbutamid. These drugs stimulate
the B cells in producing more insulin, and if the cells are not completely ex-
hausted, the hyperglycaemia can thus be reverted to normoglycaemia (normal
blood glucose levels).
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(2) Biguanides (BG)
(4) Insulin
(3) alpha−Glucosidase
inhibitors
(1) Sulfonylureas (SU)
Insulin
IntestinesLangerhans islets
Pancreas
Muscles
Liver
Fig. 2. Summary of drugs and mechanisms controlling the blood level of glucose;
− − →: inhibition, · · · · · ·→: stimulation.
• Use of biguanides (BG), such as metformin. These drugs inhibit the release
of glucose from the liver.
• Use of α-glucosidase inhibitors. These drugs inhibit (or delay) the absorption
of glucose from the intestines.
• Injection of insulin. This is the ultimate, causal treatment.
As insulin is typically administered by injection, in contrast to the other drugs
which are normally taken orally, doctors prefer to delay prescribing insulin as long
as possible. Thus, the treatment part of the diabetes type 2 guideline mentions that
one should start with prescribing oral antidiabetics (SU or BG, cf. Fig. 1). Two of
these can also be combined if taking only one has insufficient glucose-level lowering
effect. If treatment is still unsatisfactory, the guideline suggests to: (1) either add
insulin, or (2) stop with the oral antidiabetics entirely and to start with insulin.
From a medical point of view, advice (1) above is somewhat curious. If the oral
antidiabetics are no longer effective enough, the B cells could be completely ex-
hausted. Under these circumstances, it does not make a lot of sense to prescribe
an SU drug. The guideline here assumes that the B cells are always somewhat ac-
tive, which may limit the amount of insulin that has to be prescribed. Similarly,
prescription of a BG (or a α-glucosidase inhibitor) is justified, as by adding such
an oral antidiabetic to insulin, the number of necessary injections can be reduced
from twice a day to once a day. It should be noted that, when on insulin treatment,
patients run the risk of getting hypoglycaemia, which is a side effect of insulin
treatment not mentioned explicitly in the guideline.
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The background knowledge concerning the (patho-)physiology of the glucose
metabolism as described above is formalised using temporal logic, and kept as
simple as possible. The specification is denoted by BDM2:
(1) GDrug(insulin)→ G(uptake(liver, glucose) = up ∧
uptake(peripheral-tissues, glucose) = up)
(2) G(uptake(liver, glucose) = up→ release(liver, glucose) = down)
(3) (GDrug(SU) ∧ ¬capacity(b-cells, insulin) = exhausted)
→ Gsecretion(b-cells, insulin) = up
(4) GDrug(BG)→ Grelease(liver, glucose) = down
(5) (Gsecretion(b-cells, insulin) = up ∧ capacity(b-cells, insulin) = subnormal ∧
QI ≤ 27 ∧ HCondition(hyperglycaemia)) → GCondition(normoglycaemia)
(6) (Grelease(liver, glucose) = down ∧ capacity(b-cells, insulin) = subnormal ∧
QI > 27 ∧ HCondition(hyperglycaemia)) → GCondition(normoglycaemia)
(7) ((Grelease(liver, glucose) = down ∨ Guptake(peripheral-tissues, glucose) = up) ∧
capacity(b-cells, insulin) = nearly-exhausted ∧ Gsecretion(b-cells, insulin) = up ∧
HCondition(hyperglycaemia)) → GCondition(normoglycaemia)
(8) (Guptake(liver, glucose) = up ∧ Guptake(peripheral-tissues, glucose) = up) ∧
capacity(b-cells, insulin) = exhausted ∧ HCondition(hyperglycaemia))
→ G(Condition(normoglycaemia) ∨ Condition(hypoglycaemia))
(9) (Condition(normoglycaemia) ⊕ Condition(hypoglycaemia) ⊕
Condition(hyperglycaemia)) ∧ ¬(Condition(normoglycaemia) ∧
Condition(hypoglycaemia) ∧ Condition(hyperglycaemia))
where ⊕ stands for the exclusive OR. Note that when the B cells are exhausted,
increased uptake of glucose by the tissues may result not only in normoglycaemia
but also in hypoglycaemia. Note that this background knowledge was originally
developed for reasoning about the application of a single treatment. It requires some
modification in order to reason about the whole guideline fragment (see Section 5.5).
4.3 Quality Check
The consequences of various treatment options can be examined using the method
introduced in Section 3. Hypothetical patients for whom it is the intention to reach
a normal level of glucose in the blood (normoglycaemia) and one of the steps in the
guideline is applicable in the guideline fragment given in Fig. 1, are considered, for
example:
• Consider a patient with hyperglycaemia due to nearly exhausted B cells. For
these patients, the third step of Fig. 1 is applicable, so we check that:
BDM2 ∪ GT ∪ {capacity(b-cells, insulin) = nearly-exhausted} ∪
{HCondition(hyperglycaemia)}  GCondition(normoglycaemia)
holds for T = {Drug(SU),Drug(BG)}, which also satisfies the minimality condition
O⊂(T ).
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Fig. 3. Translation of medical knowledge.
• Prescription of treatment T = {Drug(SU),Drug(BG),Drug(insulin)} for a
patient with exhausted B cells, for which the intended treatment regime is
described in the fourth step of Fig. 1, yields:
BDM2 ∪ G T ∪ {capacity(b-cells, insulin) = exhausted} ∪
{HCondition(hyperglycaemia)} 
G(Condition(normoglycaemia) ∨ Condition(hypoglycaemia))
In the last case, it appears that it is possible that a patient develops hypoglycaemia
due to treatment; if this possibility is excluded from axiom (8) in the background
knowledge, then the minimality condition O⊂(T ), and also Oc(T ), does not hold
since insulin by itself is enough to reach normoglycaemia. In either case, good prac-
tice medicine is violated, which is to prescribe as few drugs as possible, taking into
account costs and side-effects of drugs. Here, three drugs are prescribed whereas
only two should have been prescribed (BG and insulin, assuming that insulin alone
is too costly), and the possible occurrence of hypoglycaemia should have been pre-
vented.
5 Automated Quality Checking
As mentioned in the introduction, we have explored the feasibility of using auto-
mated reasoning tools to check the quality of guidelines, in the sense described
above.
5.1 Motivation for using Automated Reasoning
Several techniques are available for reasoning with temporal logic. Firstly, an au-
tomated theorem prover aims at proving theorems without any interaction from
the user. This is a problem with high complexity; e.g., for first-order logic, this
problem is recursively enumerable. For this reason, interactive theorem proving has
14 Arjen Hommersom, Peter J.F. Lucas, and Patrick van Bommel
been used as an alternative, where it is possible and sometimes necessary to give
hints to the system. As a consequence, more complicated problems can be handled;
however, in the worst case every step of the proof has to be performed manually.
For our work, it is of interest to obtain insight how much of the proof effort can be
automated as this would clearly improve the practical usefulness of employing for-
mal methods in the process of guideline development. In our previous work we have
considered using interactive theorem proving (Hommersom et al. 2007). This was a
successful experiment; however, the number of interactions that were needed were
still high and a lot of expertise in the area of theorem proving is required for carrying
out this task. Furthermore, there has been considerable progress in terms of speed
and the size of problems that theorem provers can handle (Pelletier et al. 2002). In
our opinion, these developments provide enough justification to explore the use of
automated reasoning techniques in combination with specific strategies.
One of the most important application areas of model finders and theorem provers
is program verification. In programs there is a clear beginning of the execution,
which makes it intuitive to think about properties that occur after the start of
the program. Therefore, it is not surprising that much work that has been done
in the context of model finding and theorem proving only deals with the future
time modality. However, it is more natural to model medical knowledge with past
time operators, i.e., what happened to the patient in the past. It is well-known that
formulas with a past-time modality can be mapped to a logical formula with only
future time modalities such that both formulas are equivalent for some initial state
(Gabbay 1989). The main drawback of this approach is that formulas will get much
larger in size (Markey 2003) and as a consequence become much harder to verify
in a theorem prover designed for modal logics.
For this reason, we have chosen to use an alternative approach which uses a
relational translation to map the temporal logic formulas to first-order logic. As
primary tools we used the resolution-based theorem prover otter (McCune 2003)
and the finite model searcher mace-2 (McCune 2001), which take first-order logic
with equality as their input. These systems have been optimised for reasoning
with first-order logical formulas and offer various reasoning strategies to do this
efficiently. For example, otter offers the set-of-support strategy and hyperres-
olution as efficient reasoning methods. There are alternative systems that could
have been used; however, it is not the aim of this paper to compare these sys-
tems. otter has been proven to be robust and efficient, and has been successfully
applied to solve problems of high complexity, for example in the area of algebra
(Phillips and Vojteˇchovskiy´ 2005) and logic (Jech 1995).
There has been work done to improve the speed of resolution-based theorem
provers on modal formulas (Areces et al. 2000), but again, converse modalities such
as the past-time operators are not considered. We found that the general heuristics
applicable to full first-order logic are sufficient to our task.
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5.2 Translation
In order to prove meta-level properties, it is necessary to reason at the object-level.
Object-level properties typically do not contain background knowledge concerning
the validity what it being verified. For example, the (M2) property of Section 3 has
a clear meaning in terms of clinical guidelines, which would be lost if stated as an
object-level property. Moreover, it is not (directly) possible to state that something
does not follow at the object level. Fig. 3 summarises the general approach. We will
first give a definition for translating the object knowledge to standard logic and
then the translation of the meta-level knowledge will follow.
5.2.1 Translation of Object Knowledge
The background knowledge, as defined in Subsection 4.2, is translated into first
order logic. For every function f with two elements in the co-domain, call these
{c1, c2}, we introduce a fresh variable p for every element a in the domain such that
f(a) = c1 holds iff p holds, and f(a) = c2 holds iff ¬p holds. For example, axiom
(2) of BDM2 in Section 4.2 is represented by defining ‘uptake(liver, glucose) = up’
and ‘release(liver, glucose) = up)’ as propositions and rewriting this axiom as:
G(‘uptake(liver, glucose) = up’→ ¬(‘release(liver, glucose) = up’))
For the capacity function, a function with three elements in its co-domain, we add
a proposition px for each expression capacity(b-cells, insulin) = x and an axiom
saying that each pair of these propositions are mutually exclusive. Finally, the term
QI > 27 is interpreted as a proposition as well, i.e., we do not reason about the
numerical value of QI.
Technically, this translation is not required, since we could extend the translation
below to full first-order temporal logic. In practice however, we would like to avoid
additional complexity from first-order formulas during the automated reasoning.
The relational translation (e.g., (Moore 1979; Areces et al. 2000; Schmidt and Hustadt 2003))
STt(ϕ), also referred to as the standard translation, translates a propositional tem-
poral logical formula ϕ into a formula in a first-order logic with (time-indexed)
unary predicate symbols P for every propositional variable p and one binary pred-
icate >. It is defined as follows, where t is an individual variable standing for time:
STt(p) iff P (t)
STt(¬ϕ) iff ¬STt(ϕ)
STt(ϕ ∧ ψ) iff STt(ϕ) ∧ STt(ψ)
STt(Gϕ) iff ∀t
′ (t 6> t′ → STt′(ϕ))
STt(Hϕ) iff ∀t
′ (t > t′ → STt′(ϕ))
Note that the last two elements of the definition give the meaning of the G modality
and its converse, the H modality. For example, the formula G(p → Pp) translates
to ∀t2 (t 6> t2 → (P (t2)→ ∃t3 (t2 > t3 ∧ P (t3))). It is straightforward to show that
a formula in temporal logic is satisfiable if and only if its relational translation is.
Also, recall that we use set union to denote conjunction, thus STt(Γ∪∆) is defined
as STt(Γ) ∧ STt(∆).
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In the literature a functional approach to translating modal logic has appeared as
well (Ohlbach 1988), which relies on a non-standard interpretation of modal logic
and could be taken as an alternative to this translation.
5.2.2 Translation of Meta-level Knowledge
Again, we consider the criteria for good practice medicine and make them suitable
for use with the automated reasoning tools. In order to stress that we deal with
provability in these tools, we use the ‘⊢’ symbol instead of the ‘|=’ (validity) symbol.
We say that a treatment T is a treatment complying with the requirements of good
practice medicine iff:
(M1′) STt(B ∪ GT ∪ C ∪R) 0 ⊥
(M2′) STt(B ∪ GT ∪ C ∪R ∪ ¬N) ⊢ ⊥
(M3′) ∀T ′ ⊂ T : T ′ is not a treatment according to (M1′) and (M2′)
Criterion (M3′) is a specific instance of (M3), i.e., subset minimality as explained
in Section 3 (Equation (3)). As the relational translation preserves satisfiability,
these quality requirements are equivalent to their unprimed counterparts in Section
3. To automate this reasoning process we use mace-2 to verify (M1′), otter to
verify (M2′), and (M3′) can be seen as a combination of both for all subsets of
the given treatment.
5.3 Results
In this subsection we will discuss the actual implementation in otter and some
results obtained by using particular heuristics.
5.3.1 Resolution Strategies
An advantage that one gains from using a standard theorem prover that a whole
range of different resolution rules and search strategies are available and can be var-
ied depending on the problem. otter uses the set-of-support strategy (Wos et al. 1965)
as a standard strategy. In this strategy the original set of clauses is divided into a
set-of-support and a usable set such that in every resolution step at least one of the
parent clauses has to be member of the set-of-support and each resulting resolvent
is added to the set-of-support.
Looking at the structure of the formulas in Section 4, one can see that formulas
are of the form p0 ∧ · · · ∧ pn → q, where p0 ∧ · · · ∧ pn and q are almost all positive
literals. Hence, we expect the occurrence of mainly negative literals in our clauses,
which can be exploited by using negative hyperresolution (neg hyper for short)
(Robinson 1965) in otter. With this strategy a clause with at least one positive
literal is resolved with one or more clauses only containing negative literals (i.e.,
negative clauses), provided that the resolvent is a negative clause. The parent clause
with at least one positive literal is called the nucleus, and the other, negative, clauses
are referred to as the satellites.
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5.3.2 Verification of Treatments
The ordering predicate> that was introduced in Section 5.2.1 was defined by adding
axioms of irreflexivity, anti-symmetry, and transitivity. We did not find any cases
where the axiom of transitivity was required to construct the proof, which can be
explained by the low modal depth of our formulas. As a consequence, the axiom
was omitted with the aim to improve the speed of theorem proving. Furthermore,
because we lack the next step modality, we did not need to axiomatise a subsequent
time point. Experiments showed that this greatly reduces the amount of effort for
the theorem prover.
We used otter to perform the two proofs which are instantiations of (M2′).
First we, again, consider a patient with hyperglycaemia due to nearly exhausted
B cells and prove:
ST0(BDM2 ∪ G T ∪ {capacity(b-cells, insulin) = nearly-exhausted}
∪ {HCondition(hyperglycaemia)}
∪ {¬GCondition(normoglycaemia)}) ⊢ ⊥
where T = {Drug(SU),Drug(BG)}, i.e., step 3 of the guideline (see Fig. 1). Note
that we use ‘0’ here to represent the current time point. This property was proven
using otter in 62 resolution steps with the use of the negative hyperresolution
strategy. A summary of this proof can be found in Appendix Appendix A.
Similarly, given T = {Drug(SU),Drug(BG),Drug(insulin)} to a patient with ex-
hausted B cells, as suggested by the guideline in step 4, it follows that:
ST0(BDM2 ∪ GT ∪ {capacity(b-cells, insulin) = exhausted} ∪
{HCondition(hyperglycaemia)} ∪
{¬(G(Condition(normoglycaemia) ∨ Condition(hypoglycaemia)))}) ⊢ ⊥
However, if we take T = {Drug(insulin}, the same holds, which shows that, as
already mentioned in Section 4.3, that even if we ignore the fact that the patient may
develop hypoglycaemia, the treatment is not minimal. Compared to the previous
property, a similar magnitude of complexity in the proof was observed, i.e., 52
resolution steps.
5.3.3 Using Weighting
One possibility to improve the performance is by using term ordering strategies.
This will be explained below, but first we give a motivating example why this is
particularly useful for this class of problems. Consider the following example taken
from (Areces et al. 2000). Suppose we have the formula G(p → Fp). Proving this
satisfiable amounts to proving that the following two clauses are satisfiable:
1. 0 > t1 ∨ ¬P (t1) ∨ t1 6> f(t1)
2. 0 > t2 ∨ ¬P (t2) ∨ P (f(t2))
It can be observed, that although we have two possibilities to resolve these two
clauses, for example on the P literal, this is useless because the negative P literal is
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Weights Clauses (binary res) Clauses (negative hyper res)
(0, 1) 17729 6994
(1, 0) 13255 6805
(1, 1) 39444 7001
(1,−1) 13907 6836
(2,−2) 40548 7001
(2,−3) 16606 6805
(3,−4) 40356 7095
(3,−5) 27478 7001
Fig. 4. Generated clauses to prove an instance of property M2′ depending on
weights (x, y) for the ordering relation on time.
only bound by the G-operator while the positive P literal comes from a formula at
a deeper modal depth under the F-operator. Suppose we resolve these ¬P (t1) and
P (f(t2)) and rename t2 to t, which generates the clause:
0 > f(t) ∨ f(t) 6> f(f(t)) ∨ 0 > t ∨ ¬P (t)
and with (2) again we have:
0 > f(f(t)) ∨ f(f(t)) 6> f(f(f(t))) ∨ 0 > f(t) ∨ c > t ∨ ¬P (t)
etc. In this way, we can generate many new increasingly lengthy clauses. Clearly,
these nestings of the Skolem functions will not help to find a a contradiction more
quickly if the depth of the modalities in the formulas that we have is small, as
the new clauses are similar to previous clauses, except that they describe a more
complex temporal structure.
In otter the weight of the clauses determines which clauses are chosen from
the set-of-support and usable list to become parents in a resolution step. In case
the weight of two clauses is the same, there is a syntactical ordering to determine
which clause has precedence. This is called the Knuth-Bendix Ordering (KBO)
(Knuth and Bendix 1970). As the goal of resolution is to find an empty clause,
lighter clauses are preferred. By default, the weight of a clause is the sum of all
occurring symbols (i.e., all symbols have weight 1) in the literals. As we have ar-
gued, since the temporal structure of our background knowledge is relatively simple,
nesting Skolem functions will not help to find such an empty clause. Therefore it
can be of use to manually change the weight of the ordering symbol, which is done
in otter by a tuple (x, y) for each predicate, where x is multiplied by the sum of
the weight of its arguments and is added to y to calculate the new weight of this
predicate. For example, if x = 2 and y = −3, then v > w has a total weight of
2 + 2− 3 = 1, and f(f(c)) > f(d) has a weight of 2 ∗ 3 + 2 ∗ 2− 3 = 7.
See Fig. 4 where we show results when we applied this for some small values for
x and y for both binary and negative hyperresolution. What these numbers show
(similar results were obtained for the other property) is that the total weight of the
ordering predicate should be smaller than the weight of other, unary, predicates.
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> : Condition(hyperglycaemia) :
t | 0 1 t 0 1
---+---- -------
0 | F T T T
1 | F F
Drug(SU): Drug(BG) :
t 0 1 t 0 1
------- -------
F F T F
capacity(b-cells, insulin) = nearly-exhausted :
t | 0 1
-------
T T
Fig. 5. Snippet from a mace-2 generated model. It lists the truth value of all the
unary predicates given each element of the domain (i.e., the time points ‘0’ and
‘1’) and every combination of domain elements for the binary predicate <. Truth
values are denoted by T (true) and F (false).
Possibly somewhat surprisingly, the factor x should not be increased too much.
Furthermore, in the case of a negative hyperresolution strategy the effect is minimal.
5.4 Disproofs
mace-2 (Models And CounterExamples) is a program that searches for small finite
models of first-order statements using a Davis-Putman-Loveland-Logemann deci-
sion procedure (Davis and Putman 1969; Davis et al. 1962) as its core. Because of
the relative simplicity of our temporal formulas, it is to be expected that counterex-
amples can be found rapidly, exploring only few states. Hence, it could be expected
that models are of the same magnitude of complexity as in the propositional case
and this was indeed the case. In fact, the countermodels that mace-2 found consist
of only 2 elements in the domain of the model.
The first property we checked corresponded to checking whether the background
knowledge augmented with patient data and a therapy was consistent, i.e., criterion
(M1′). Consider a patient with hyperglycaemia due to nearly exhausted B cells.
We used mace-2 to verify:
ST0(BDM2 ∪ G T ∪ {capacity(b-cells, insulin) = exhausted} ∪
{HCondition(hyperglycaemia)}) 0 ⊥
for T = {Drug(SU),Drug(BG),Drug(insulin)}. From this it follows that there is a
model if T = {Drug(SU),Drug(BG)} and consequently we have verified (M1′).
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Similarly, we found that for all T ⊂ {Drug(SU),Drug(BG)}, it holds that:
ST0(BDM2 ∪ G T ∪ {capacity(b-cells, insulin) = nearly-exhausted}
∪ {HCondition(hyperglycaemia)}
∪ {¬GCondition(normoglycaemia)}) 0 ⊥
i.e., it is consistent to believe the patient will not have normoglycaemia if less
drugs are applied, which violates (M2) for these subsets. So indeed the conclusion
was that the treatment complies with (M3′) and thus complies with the criteria of
good practice medicine. See for example Fig. 5, which contains a small sample of the
output that mace-2 generated. The output consists of a first-order model with two
elements in the domain, named ‘0’ and ‘1’, and an interpretation of all predicates
and functions in this domain. It shows that it is consistent with the background
knowledge to believe that the patient will continue to suffer from hyperglycaemia
if one of the drugs is not applied. Note that the model specifies that biguanide is
applied at the first time instance, as this is not prohibited by the assumptions.
Finally, consider the treatment T = {Drug(SU),Drug(BG),Drug(insulin)} for a
patient with exhausted B cells, we can show that:
ST0(BDM2 ∪ GT ∪ {capacity(b-cells, insulin) = exhausted} ∪
{HCondition(hyperglycaemia)} ∪
{G(Condition(normoglycaemia)))}) 0 ⊥
so the patient may be cured with insulin treatment, even though this is not guaran-
teed as Condition(normoglycaemia) does not deductively follow from the premises.
However, it is possible to prove the same property when T = {Drug(insulin)} and
thus (M3′) does not hold in this case and as a consequence the guideline does not
comply with the quality requirements as discussed in Section 4.3.
5.5 Plan Structure
So far, we have not considered the order in which treatments are being considered
and executed. In this subsection, we look at the problem of reasoning about the
order of treatments described in the treatment plan listed in Fig. 1.
5.5.1 Formalisation
In order to reason about a sequence of treatments, additional formalisation is re-
quired. The background knowledge was developed for reasoning about an individual
treatment, and therefore, is parameterised for the treatment that is being applied.
We postulate BDM2, parameterised by s, where s is a certain step in the protocol,
i.e., s = 1, 2, 3, 4 (cf. Fig. 1; for example s = 1 corresponds to diet). The first axiom
is then described by:
∀s (GDrug(insulin, s)→ G(uptake(liver, glucose, s) = up))
The complete description of this background knowledge is denoted by B′DM2 The
reason for this is that the ‘G’ modality ranges over the time period of an individ-
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ual treatment, rather than the complete time frame. Similarly, the patient can be
described, assuming the description of the patient description does not change, by
∀s P (s), where P is a parameterised description of the patient. For example, in
diabetes, it may be assumed that the Quetelet index does not change; however, the
condition generally does change due to the application of a treatment.
The guideline as shown in Fig. 1 is modelled in two parts. First, we need to
specify which treatment is administered in each step of the protocol. Second, the
transition of one step to the next has to be specified. The former is modelled as a
conjunction of treatments for each step of the guideline. For example, in the initial
treatment step (i.e., step 1) only ‘diet’ is applied, hence, the following is specified:
G diet(1)
In general, for treatment T (s) in step s, we write GT (s). Here s is a meta-variable
standing for the step in the protocol, i.e., it is a ground atom in the concrete
specification of the protocol. Object-level variables can be recognised by the fact
that they are bounded by quantification. For example, T (s) is a ground term in
the actual specification, while ∀s T (s) is not. In this notation, we will refer to
the set of treatment prescriptions for each step and all patient groups P (s) as
D =
⋃
s P (s)→ GT (s).
The second part of the formalisation concern the change of treatments, which
is formalised by a predicate control(s) that describes which step of the guideline
will be reached. Recall from Fig. 1, that treatments are stopped in case they fail,
i.e., when they do not result in the desired effect. This change of control can be
described in the meta-language as:
B ∪ GT (s) ∪ P (s) 6|= N(s)⇒ control(s+ 1) (5)
for all steps s, i.e., if the intention cannot be deduced, then we move to a subsequent
step. We will refer to this axiom as the control axiom C. It is not required that the
control is mutually exclusive: if control(s + 1) holds, then control(s) also holds,
although the converse is not necessarily true. Note that ¬N(s) cannot be deduced
from the background knowledge, due to its causal nature; however, clearly, in the
context of automatic reasoning, it is useful to reason about the theory deductively.
To be able to do this, one can use the so-called completed theory, denoted as
COMP(Γ), where Γ is some first-order theory. The COMP function is formally
defined in (Clark 1978) for general first-order theories. For propositional theories
one can think of this function as replacing implication with bi-implications, for
example, COMP(p→ q) = p ↔ q and COMP({p→ q, p → r}) = p ↔ (q ∨ r). By
the fact that the temporal formulas can be interpreted as first-order sentences, we
have for example:
COMP(GDrug(insulin)→ G uptake(liver, glucose) = up)
= GDrug(insulin)↔ G uptake(liver, glucose) = up
This can be extended for the whole set of axioms of diabetes. The relevance of
this operator for this chapter, is that abductive reasoning can be seen as deductive
reasoning in this completed theory (Console et al. 1991). In the following section,
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we introduce an extension to this idea for the restricted part of temporal logic
described in Section 3. These results are based on a direct application of work done
by Sta¨rk (Sta¨rk 1994). Then, we will apply those results to the above formalisation.
5.5.2 Completion
An important resolution strategy is SLD resolution which is linear resolution with
a selection function for Horn clauses, i.e., clauses with at most one positive literal
(for a definition see for example (Lucas and van der Gaag 1991)). SLD resolution
is sound and refutation complete for Horn clause logic. It is refutation complete
in the sense that if one would use a breadth-first strategy through the tree of all
SLD derivations, a finite SLD refutation will be found if the set of Horn clauses is
unsatisfiable. Below, as a convenience, we will write that we derive ψ from ϕ using
SLD resolution iff there is an SLD refutation from ϕ ∧ ¬ψ.
SLDNF resolution augments SLD resolution with a so-called ‘negation as failure’
(NAF) rule (Clark 1978). The idea is in order to prove ¬A, try proving A; if the
proof succeeds, then the evaluation of ¬A fails; otherwise, if A fails on every eval-
uation path, then ¬A succeeds. The latter part of this strategy is not a standard
logical rule and could be described formally as, given some theory Γ, if Γ 6⊢ A then
Γ ⊢ ¬A is concluded. It must be noted that the query A must be grounded. This
type of inference is featured in logic programming languages such as prolog, al-
though most implementations also infer the negation as failure for non-ground goal
clauses.
This type of resolution is used here to show that a completed theory can be used in
a deductive setting to reason about the meta-theory. In particular, in (Sta¨rk 1994),
this is used to show that a certain class of programs have the property that if
a proposition deductively follows from that program, then there is a successful
SLDNF derivation. This is shown by so-called input/output specifications, which
are given by a set of mode specifications for every predicate. A mode specifica-
tion for a predicate says which arguments are input arguments and which argu-
ments are output arguments; other arguments are called normal arguments. Given
an input/output specification a program must be written in such a way that in
a computed answer the free variables of the output terms are contained in the
free variables in the input terms. Furthermore, the free variables of a negative lit-
eral must be instantiated to ground terms during a computation. For example, the
following well-known logic program
append([], L, L).
append(L1, L2, L3)→ append([X |L1], L2, [X |L3]).
has two mode specifications. Either the first two arguments are input arguments
resulting in a concatenation of the two lists in the output argument, or, the first
two arguments can act as output arguments resulting in the decomposition of the
third argument into two lists.
In the following, we will write all ground atoms without arguments, e.g., we
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denote A when we mean A(c), where c is some constant, unless the constant is
relevant. We then prove the following lemma.
Lemma 1
If COMP(Γ) |= ¬Ag, where Γ is a formula of the form:
∀s∀t (A0(s) ∧ · · · ∧ An(s) ∧ An+1(t, s) ∧ · · · ∧Am(t, s)→ Ak(t, s))
where Ai are all positive atoms and Ag is any ground atom, then there exists an
SLDNF derivation of ¬Ag for theory Γ.
A proof can be found in Appendix Appendix B. Note here that Γ only contains Horn
clauses. Further note that the relation between the completed theory and SLDNF
derivation holds for a much more elaborate class of formulas (Sta¨rk 1994). Hence,
this result could be generalised to a more elaborate temporal descriptions. However,
the fact that we are dealing with Horn clauses yields the following property, which
is the main result of this section.
Theorem 1
If Γ is in the form as assumed in Lemma 1, A is again any ground atom, and it
holds that COMP(Γ) |= ¬A, then Γ 6|= A.
Proof
Suppose COMP(Γ) |= ¬A. Then by Lemma 1 it holds that ¬A is derived by SLDNF
resolution from Γ. From the definition of SLDNF derivation either ¬A holds by SLD
resolution or a derivation for A fails. In either way, it follows from the soundness
of SLD resolution that deriving A from Γ using SLD resolution will fail. Since each
of the clauses is Horn and SLD resolution is complete for these Horn clauses, it
follows that Γ 6|= A.
5.5.3 Implementation
The result of Theorem 1 is used to investigate the completion of a restricted subset of
temporal logic. To simplify matters, we introduce the following assumptions. First,
the H operator is omitted. In this case, this is justified as this operator only plays a
role to denote the fact that the patient suffers from hyperglycaemia and plays no role
in the temporal reasoning. Hence, we have a (propositional) variable that expresses
exactly the fact that in the past the condition was hyperglycaemic. Second, as there
is no reasoning about the past, we may translate Gϕ to ∀t ϕ(t). Finally, we only
make a distinction between whether the glucose level is decreasing or not, i.e., we
abstract from the difference between normo- and hypoglycaemia. Furthermore, we
assume that the mutual exclusion of values for capacity is omitted and part of
the description of the patient, i.e., a patient with QI > 27 is now described by
{QI > 27,¬(QI ≤ 27)}. We will refer to these translation assumptions in addition
to the translation to first-order logic described in Section 5.2.1 as ST′t. Furthermore,
let COMP(Γ) be understood as the formula which is equivalent according to ST to
COMP(ST′t(Γ)) whenever Γ is a theory in temporal logic. Note that this abstraction
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Temporal Logic First-order Logic
A1 ∧ · · · ∧An ∧ GAn+1∧ ∀t (A1 ∧ · · · ∧An ∧An+1∧
· · · ∧ GAm → GAi · · · ∧Am → Ai(t))
G(A1 ∧ · · · ∧An → Ai) ∀t (A1(t) ∧ · · · ∧An(t)→ Ai(t))
GAi, Ai Ai(t), Ai
¬GAi ¬Ai
Fig. 6. The type of temporal formulas and their translation, where the Skolem
constants describing time instances are omitted.
is sound, in the sense that anything that is proven with respect to the condition of
the patient by the abstracted formulas can be proven from the original specification.
Let pi be a patient characteristic, d a drug, and li either a patient characteristic
or drug. The temporal formulas that are allowed are listed in Fig. 6. We claim that
each temporal formula is an instance of a temporal formula mentioned in Fig. 6,
universally quantified by a step s, except for the last goal clause which is grounded.
The background knowledge can be written in terms of the first and second clause,
taken into account that axiom (7) can be rephrased to two clauses of the first
type and we need to make sure that each literal is coded as a positive atom. This
is a standard translation procedure that can be done for many theories and is
described in e.g., (Shepherdson 1987, p. 23). Axiom (3) needs to be rewritten for
each of the cases of capacity implied by the negated sub-formula. For each drug
and patient characteristic in the hypothesis, the third clause of Fig. 6 applies. A
goal is an instance of the fourth clause of Fig. 6. As the first three clauses are Horn,
Theorem 1 can be instantiated for the background knowledge, which yields:
Theorem 2
COMP(B′DM2 ∪ GT (s) ∪ P (s)) |= ¬N(s) implies B
′
DM2 ∪ P (s) ∪ GT (s) 6|= N(s).
This states that, if the completed theory implies that the patient will not have
normoglycaemia, then this is consistent conclusion with respect to the original
specification, for any specific step described by s. Therefore, there is no reason to
assume that T is the correct treatment in step s. This result is applied to the control
axiom C as described in Section 5.5.1, i.e., formula 5. If we were to deduce that
COMP(B ∪ GT (s) ∪ P (s)) |= ¬N(s)
then, assuming the literals are in a proper form required by Theorem 2, this implies
that
B ∪ G T (s) ∪ P (s) 6|= N(s)
Thus, we postulate the following axiom describing the change of control, denoted
by C′
COMP(B ∧ GT (s) ∧ P (s)) ∧ ¬N(s)→ control(s+ 1)
The axioms D (cf. Section 5.5.1) and C′ are added to the guideline formalisation in
order to reason about the structure of the guideline.
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To investigate the quality of the treatment sequence, a choice of quality criteria
has to be chosen. Similarly to individual treatments, notions of optimality could be
studied. Here, we investigate the property that for each patient group, the intention
should be reached at some point in the guideline. For the diabetes guideline, this
is formalised as follows:
B′DM2 ∪ D ∪ ∀s P (s) |= ∃s N(s)
As we restrict ourselves to a particular treatment described in step s, this property
is similar to the property proven in Section 5.3. However, it is possible that the
control never reaches s for a certain patient group, hence, using the knowledge
described in C, it is also important to verify that this step is indeed reachable, i.e.,
B′DM2 ∪ D ∪ ∀s P (s)) ∪ C
′ |= ∃s (N(s) ∧ control(s))
The above was used to verify a number of properties for different patient groups.
For example, assume
P (s) = {capacity(liver, glucose, s) = exhausted,QI(s) ≤ 27,
HCondition(normoglycaemia)}
(note the H operator is abstracted from the specification) then:
B′DM2 ∪ D ∪ ∀s P (s) ∪ C
′ |= GCondition(normoglycaemia, 3) ∧ control(3)
i.e., the third step will be reached and in this step the patient will be cured. This was
implemented in otter using the translation as discussed in the previous subsection.
As the temporal reasoning is easier due to the abstraction that was made, the proofs
are reasonably short. For example, in the example above, the proof has length 25
and was found immediately.
6 Conclusions
The quality of guideline design is for the largest part based on its compliance with
specific treatment aims and global requirements. We have made use of a logical
meta-level characterisation of such requirements, and with respect to the require-
ments use was made of the theory of abductive, diagnostic reasoning, i.e., to diag-
nose potential problems with a guideline (Lucas 1997; Lucas 2003; Poole 1990). In
particular, what was diagnosed were problems in the relationship between medical
knowledge, and suggested treatment actions in the guideline text and treatment ef-
fects; this is different from traditional abductive diagnosis, where observed findings
are explained in terms of diagnostic hypotheses. This method allowed us to examine
fragments of a guideline and to prove properties of those fragments. Furthermore,
we have succeeded in proving a property using the structure of the guideline, namely
that the blood glucose will go down eventually for all patients if the guideline is
followed (however, patients run the risk of developing hypoglycaemia).
In earlier work (Hommersom et al. 2007), we used a tool for interactive program
verification, named KIV (Reif 1995), for the purpose of quality checking of the di-
abetes type 2 guideline. Here, the main advantage of the use of interactive theorem
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proving was that the resulting proofs were relatively elegant as compared to the
solutions obtained by automated resolution-based theorem proving. This may be
important if one wishes to convince the medical community that a guideline com-
plies with their medical quality requirements and to promote the implementation
of such a guideline. However, to support the design of guidelines, this argument is
of less importance. A push-button technique would there be more appropriate. The
work that needs to be done to construct a proof in an interactive theorem prover
would severely slow down the development process as people with specialised knowl-
edge are required.
Another method for verification that is potentially useful is model checking. One
advantage is that it allows the end user, in some cases, to inspect counter example
if it turns out that that a certain quality requirement does not hold. The main
disadvantage is that the domain knowledge as we have used here is not obviously
represented into a automaton, as knowledge stated in linear temporal logic usually
cannot succinctly be translated to such a model.
One of the main challenges remains bridging the gap between guideline devel-
opers and formal knowledge needed for verification. The practical use of the work
that is presented here depends on such developments, although there are several
signs that these developments will occur in the near future. Advances in this area
have been made in for example visualisation (Kosara and Miksch 2001) and in-
teractive execution of guideline representation languages. Furthermore, the repre-
sentation that we have used in this paper is conceptually relatively simple com-
pared to representation of guidelines and complex temporal knowledge discussed
in for example (Shahar and Cheng 2000), however, in principle all these mecha-
nisms could be formalised in first-order logic and could be incorporated in this
approach. Similarly, probabilities have been ignored in this paper, for which several
probabilistic logics that have been proposed in the last couple of years seem appli-
cable in this area (Richardson and Domingos 2006; Kersting and De Raedt 2000).
Exploring other types of analysis, including quantitative and statistical, could have
considerable impact, as we are currently moving into an era where guidelines are
evolving into highly structured documents and are constructed more and more us-
ing information technology. It is not unlikely that the knowledge itself will be stored
using a more formal language. Methods for assisting guideline developers looking
into the quality of clinical guidelines, for example, using automated verification will
then be useful.
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Appendix A Proof of Meta-level Property (M2)
In the formulas below, each literal is augmented with a time-index. These implicitly
universally quantified variables are denoted as t and t′. Recall that g(x, y) = down
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is implemented as ¬(g(x, y) = up) and functions f and f ′ are Skolem functions
introduced by otter. Both Skolem functions map a time point to a later time
point. Consider the following clauses in the usable and set-of-support list:
2 capacity(b-cells, insulin, t) 6= nearly-exhausted ∨
capacity(b-cells, insulin, t) 6= exhausted
14 t 6> f(t) ∨ capacity(b-cells, insulin, t) = exhausted ∨ t > t′ ∨
secretion(b-cells, insulin, t′) = up
15 ¬Drug(SU, f(t)) ∨ capacity(b-cells, insulin, t) = exhausted ∨ t > t′ ∨
secretion(b-cells, insulin, t′) = up
51 0 > t ∨Drug(SU, t)
53 capacity(b-cells, insulin, 0) = nearly-exhausted
For example, assumption (53) models the capacity of the B cells, i.e., nearly ex-
hausted at time 0 where the property as shown above should be refuted. Note
that some of the clauses are introduced in the translation to propositional logic,
for example assumption (2) is due to the fact that that values of the capacity are
mutually exclusive. This is consistent with the original formalisation, as functions
map to unique elements for element of the domain.
Early in the proof, otter deduced that if the capacity of insulin in B cells is
nearly-exhausted, then it is not completely exhausted:
56 [neg hyper,53,2] capacity(b-cells, insulin, 0) 6= exhausted
Now we skip a part of the proof, which results in information about the relation
between the capacity of insulin and the secretion of insulin in B cells at a certain
time point:
517 [neg hyper,516,53] 0 6> f ′(0)
765 [neg hyper,761,50,675]
capacity(b-cells, insulin, f ′(0)) 6= nearly-exhausted ∨
secretion(b-cells, insulin, f ′(0)) = down
This information allows otter to quickly complete the proof, by combining it
with the information about the effects of a sulfonylurea drug:
766 [neg hyper,765,15,56,517]
capacity(b-cells, insulin, f(0)) 6= nearly-exhausted ∨
¬Drug(SU, f ′(0))
767 [neg hyper,765,14,56,517]
capacity(b-cells, insulin, f(0)) 6= nearly-exhausted ∨
0 6> f(0)
after which (53) can be used as a nucleus to yield:
768 [neg hyper,767,53] 0 6> f1(0)
and consequently by taking (51) as a nucleus, we find that at time point 0 the
capacity of insulin is not nearly exhausted:
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769 [neg hyper,768,51,766]
capacity(b-cells, insulin, 0) 6= nearly-exhausted
This directly contradicts one of the assumptions and this results in an empty clause:
770 [binary,769.1,53.1] ⊥
Appendix B Proof of Lemma 1
Let Γ and Π denote lists of literals. An n-tuple (x1, . . . , xn) ∈ {in, out, normal}
n
is called a mode specification for an n-place relation symbol R ∈ Rel, denoted by
α, β, γ. The set of input variables of the atom R(t1, . . . , tn) (where ti is a term)
given a mode specification is defined by:
in(R(t1, . . . , tn), (x1, . . . , xn)) =
⋃
{vars(ti) | 1 ≤ i ≤ n, xi = in}.
Analogously, the set of output variables is given by
out(R(t1, . . . , tn), (x1, . . . , xn)) =
⋃
{vars(ti) | 1 ≤ i ≤ n, xi = out}.
An input/output specification is a function S which assigns to every n-place relation
symbol R a set S+(R/n) ⊆ {in, out, normal}n of positive mode specification and a
set S−(R/n) ⊆ {in, normal}n of negative mode specifications for R.
Definition 1 (Definition 2.1 (Sta¨rk 1994))
A clause Π → A is called correct with respect to an input/output specification S
or S-correct iff
(C1) for all positive modes α ∈ S+(A) there exists a permutation of the literals of
the body Π of the form B1, . . . , Bm,¬C1, . . .¬Cn and for all 1 ≤ i ≤ m a positive
mode βi ∈ S
+(Bi) such that
• for all 1 ≤ i ≤ m, in(Bi, βi) ⊆ in(A,α) ∪
⋃
1≤j≤i out(Bj , βj),
• out(A,α) ⊆ in(A,α) ∪
⋃
1≤j≤m out(Bj , βj),
• for all 1 ≤ i ≤ n,
S−(Ci) 6= ∅ and vars(Ci) ⊆ in(A,α) ∪
⋃
1≤j≤m out(Bj , βj),
(C2) for all negative modes α ∈ S−(A) for all positive literals B of Π there exists
a negative mode β ∈ S−(B) with in(B, β) ⊆ in(A,α) and for all negative literals
¬C of Π there exists a positive mode γ ∈ S+(C) with in(C, γ) ⊆ in(A,α).
A program P is called correct with respect to an input/output specification S iff
all clauses of P are S-correct.
Definition 2 (Definition 2.2 (Sta¨rk 1994))
A goal Γ is called correct with respect to an input/output specification S or S-
correct iff there exists a permutation B1, . . . , Bm,¬C1, . . .¬Cn of the literals of Γ
and for all 1 ≤ i ≤ m a positive mode βi ∈ S
+(Bi) such that
(G1) for all 1 ≤ i ≤ m, in(Bi, βi) ⊆
⋃
1≤j≤i out(Bj , βj),
(G2) for all 1 ≤ i ≤ m, S−(Ci) 6= ∅ and vars(Ci) ⊆
⋃
1≤j≤m out(Bj , βj).
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Theorem 3 (reformulation of Theorem 5.4 (Sta¨rk 1994))
Let P be a normal program which is correct with respect to the input/output
specification S and let L1, . . . , Lr be a goal.
(a) If COMP(P ) |= L1 ∧ . . . ∧ lr and L1, . . . , Lr is correct with respect to S then
there exists a substitution θ such that there is a successful SLDNF derivation for
L1, . . . , Lr with answer θ. (...)
Define S+ = S− = {(normal} for every unary predicate and {(normal, normal)}
for every binary predicate. Observe that Γ contains only definite clauses, so each
condition in Definition 1 is trivially satisfied, thus Γ is S-correct. Similarly, as the
goal ψ is definite, all clauses of Definition 2 are trivially satisfied, thus also S-
correct. Hence, by Theorem 3, we find that there is a successful SLDNF derivation
of ψ given Γ.
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